Rhythm Pharmaceuticals announced that its CEO and CFO will participate in fireside chats at the Jefferies Global Healthcare Conference on June 4 and the Goldman Sachs Global Healthcare Conference on June 8, 2026. These events will be webcast and accessible on the company's website. Rhythm focuses on rare neuroendocrine diseases with its lead drug, IMCIVREE (setmelanotide), approved for treating specific genetic obesity disorders. The presentations aim to update investors on company progress and clinical developments.
Electrolux Group announced a fully underwritten rights issue of approximately SEK 9 billion, approved by its Board and an Extraordinary General Meeting. The prospectus for this rights issue was approved by the Swedish Financial Supervisory Authority ...
US stock futures fell following US strikes on Iranian drone sites near the Strait of Hormuz, heightening Middle East tensions. Major indices showed slight declines, with the Russell 2000 small-cap index down. Earnings reports drew attention: Snowflak...
Autohome Inc. announced a decline in net revenues to RMB1,048.4 million (US$152.0 million) in Q1 2026 from RMB1,453.8 million in Q1 2025, primarily due to reduced advertising spending and fewer paying dealers amid shrinking auto sales. Net income att...
CIBC's Board of Directors announced a dividend of $1.07 per common share for the quarter ending July 31, 2026. The dividend will be paid on July 28, 2026, to shareholders recorded by June 29, 2026. This reflects CIBC's ongoing commitment to returning...
Investec Bank plc, acting as a joint broker for Gamma Communications Plc, disclosed a public dealing on May 27, 2026. The bank purchased and sold an equal number of 27,554 ordinary shares of Gamma Communications at prices ranging between 976.5 and 99...
